StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1241
This month
14
This week
6
This year
109
Yesterday
2
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 08
5
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
5
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
7
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 13
6
2023 - 02 - 08
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 10 - 28
4
2021 - 10 - 20
4
2021 - 08 - 31
4
2021 - 08 - 25
4
2021 - 08 - 19
5
2021 - 08 - 05
6
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 04 - 13
4
2021 - 03 - 18
5
Sector
Commercial services
12
Communications
8
Consumer durables
5
Consumer non-durables
15
Consumer services
2
Distribution services
4
Electronic technology
19
Finance
6
Health care and social assistance
1
Health services
17
Health technology
1241
Industrial services
1
Information
4
Manufacturing
136
Mining, quarrying, and oil and gas extraction
2
N/a
68
Non-energy minerals
1
Process industries
16
Producer manufacturing
22
Professional, scientific, and technical services
20
Retail trade
3
Technology services
17
Tags
America
67
Antibody
13
Application
12
Approval
21
Biosimilar
39
Breast
13
Cancer
106
Covid
17
Covid-19
12
Device
14
Diabetes
18
Diagnostics
19
Disease
76
Drug
115
Drug delivery
11
Earnings
21
Europe
17
Expansion
11
Expected
35
Eye
21
Fda
28
Financial
24
Financial results
13
Gene therapy
11
Global
229
Growing
47
Growth
262
Health
19
Immunotherapy
12
Kisqali
11
Leukemia
12
Liver
20
Market
599
N/a
1115
Novartis
133
Patent
13
People
20
Pharma
17
Pharmaceuticals
17
Pipeline
12
Positive
19
Potential
13
Reach
34
Report
195
Research
129
Respiratory
15
Results
52
Risk
11
Sales
11
Sclerosis
13
Set
16
Study
17
T-cell
12
Technology
14
Therapeutics
114
Therapy
89
Treatment
137
Trial
25
Vaccine
16
Year
12
Entities
3m company
13
Abbott laboratories
119
Abbvie inc.
239
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
15
Alcon inc.
15
Alkermes plc
10
Amgen inc.
196
Astellas pharma inc
70
Astrazeneca plc
198
Autolus therapeutics plc
7
Bausch health companies inc.
74
Baxter international inc.
48
Becton, dickinson and company
19
Beigene, ltd.
7
Biogen inc.
54
Biontech se
10
Bluebird bio, inc.
11
Boston scientific corporation
17
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
103
Csl ltd
9
Danaher corporation
11
Eli lilly and company
138
Endo international plc
20
General electric company
8
Genmab a/s
21
Gilead sciences, inc.
28
Glaxosmithkline plc
304
Grifols sa
10
Incyte corporation
21
Ionis pharmaceuticals, inc.
9
Jazz pharmaceuticals plc
14
Johnson & johnson
245
Koninklijke philips n.v.
19
Mallinckrodt plc
17
Medtronic plc
36
Morphosys ag
15
Novartis ag
1241
Novo nordisk a/s
28
Orange
8
Orchard therapeutics plc
9
Perrigo company
8
Pfizer, inc.
88
Precision biosciences, inc.
8
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
13
Regenxbio inc.
12
Sanofi
329
Stryker corporation
12
Takeda pharmaceutical company limited
58
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
51
Ucb s.a.
8
Uniqure n.v.
12
Vericel corporation
8
Viatris inc.
120
Xencor, inc.
11
Symbols
AAPL
1194
ABB
1425
ABBV
1024
ABLZF
1164
ABT
1784
ACN
600
AMGN
742
ARVL
4291
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1609
F
641
FNCTF
7182
FRBA
595
GE
915
GLAXF
657
GOOG
1274
GOOGL
1273
GSK
883
HON
1781
HUBS
1400
IBM
654
INTC
955
IT
594
JNJ
4575
LLY
1708
LTUM
970
LYV
717
MDT
1285
MMM
938
MS
4282
MSFT
1199
MT
589
NOC
589
NOK
900
NOKBF
974
NVO
631
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1475
SAPGF
1229
SNOW
794
SNY
4533
SNYNF
3591
TEVJF
630
TMO
1621
VZ
1212
XYF
676
Exchanges
Amex
7
Nasdaq
1156
Nyse
1241
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 08
6
2023 - 10 - 04
5
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
7
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 14
4
2023 - 02 - 13
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 14
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 10 - 28
4
2021 - 10 - 20
4
2021 - 09 - 01
4
2021 - 08 - 25
4
2021 - 08 - 19
5
2021 - 08 - 05
6
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 04 - 13
4
2021 - 03 - 18
5
Crawled Time
00:00
45
00:20
10
01:00
47
01:08
1
02:00
25
03:00
34
04:00
23
04:20
8
05:00
23
06:00
69
06:03
2
07:00
39
08:00
34
08:20
4
08:23
1
09:00
45
10:00
33
11:00
52
11:01
1
12:00
83
12:15
6
12:20
16
12:30
9
13:00
35
13:14
1
13:15
7
13:20
8
13:30
5
13:35
1
13:58
1
14:00
50
14:15
2
14:20
10
14:30
7
14:49
1
15:00
55
15:15
4
15:20
16
15:30
16
16:00
56
16:01
1
16:20
4
17:00
65
18:00
55
19:00
45
20:00
48
20:20
3
21:00
34
22:00
55
22:01
1
23:00
44
23:09
1
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
spacfeed.com
1
www.biospace.com
126
www.globenewswire.com
226
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
880
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVS
save search
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)
Published:
2024-01-11
(Crawled : 13:00)
- globenewswire.com
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-13.37%
|
O:
-0.22%
H:
0.43%
C:
0.37%
LNTH
|
$62.595
1.81%
840K
|
Health Technology
|
3.69%
|
O:
0.32%
H:
0.03%
C:
-4.42%
lutathera
Global Cystic Fibrosis Lung Disease Research Report 2023: Analysis and Forecasts by Drug Type, Route of Administration, Distribution Channel, Region, and Country 2019-2029
Published:
2024-01-09
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-11.87%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-13.07%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
lung
drug
disease
report
distribution
fibrosis
research
global
Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published:
2024-01-09
(Crawled : 03:00)
- prnewswire.com
ALPMF
|
News
|
$9.594
2.2K
|
Health Technology
|
-22.38%
|
O:
0.16%
H:
0.0%
C:
-3.88%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-11.87%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.46
500K
|
Manufacturing
|
-23.94%
|
O:
-1.22%
H:
0.0%
C:
-0.72%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-13.07%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-10.52%
|
O:
0.74%
H:
0.0%
C:
0.0%
AMGN
|
$263.24
-0.31%
760K
|
Health Technology
|
-14.14%
|
O:
-0.92%
H:
0.63%
C:
-0.25%
america
cancer
treatment
market
Contact Lens Solutions Market size to grow by USD 540.94 million from 2023 to 2028, Increased preference for contact lenses over spectacles to boost the market- Technavio
Published:
2024-01-09
(Crawled : 02:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-11.87%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-13.07%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
BHC
|
$8.56
-1.16%
1.1M
|
Health Technology
|
3.92%
|
O:
-0.48%
H:
6.87%
C:
-0.72%
ALC
|
$78.45
-0.7%
400K
|
Health Technology
|
2.92%
|
O:
-0.36%
H:
1.17%
C:
-0.52%
million
solutions
market
Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard‐of‐care TKIs in Phase III trial for newly diagnosed patients with chronic myeloid leukemia
Published:
2024-01-08
(Crawled : 07:00)
- globenewswire.com
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-12.44%
|
O:
0.89%
H:
0.12%
C:
-0.17%
scemblix
leukemia
trial
response
molecular
Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of market growth - Technavio
Published:
2024-01-05
(Crawled : 22:00)
- prnewswire.com
GSK
|
$39.2
-1.01%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$165.54
0.78%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
510
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$542.71
-0.83%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
AAPL
|
News
S
|
$166.77
-0.73%
26M
|
Electronic Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
GOOG
|
News
S
|
$158.08
0.77%
8.9M
|
Technology Services
|
Email alert
Add to watchlist
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.12
0.18%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
GOOGL
|
News
|
$156.52
0.68%
12M
|
Technology Services
|
Email alert
Add to watchlist
active
asia
growth
market
Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand therapy manufacturing facility in Indianapolis
Published:
2024-01-05
(Crawled : 14:30)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-10.82%
|
O:
-0.24%
H:
1.43%
C:
1.43%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-11.83%
|
O:
0.32%
H:
0.93%
C:
0.38%
novartis
advanced
therapy
Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published:
2024-01-04
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
3.48%
|
O:
2.46%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-8.98%
|
O:
0.49%
H:
0.6%
C:
-0.83%
AZNCF
|
$140.15
560
|
Health Technology
|
-1.27%
|
O:
0.15%
H:
1.88%
C:
-1.17%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-10.82%
|
O:
-0.24%
H:
1.43%
C:
1.43%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-11.83%
|
O:
0.32%
H:
0.93%
C:
0.38%
GSK
|
$39.2
-1.01%
1.2M
|
Health Technology
|
1.36%
|
O:
-0.36%
H:
0.98%
C:
0.72%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-9.61%
|
O:
-0.14%
H:
0.0%
C:
0.0%
AZN
|
$68.38
-0.22%
2.3M
|
Health Technology
|
-0.75%
|
O:
-0.68%
H:
0.87%
C:
0.1%
AMGN
|
$263.24
-0.31%
760K
|
Health Technology
|
-11.95%
|
O:
-0.32%
H:
0.44%
C:
0.26%
america
cancer
immunotherapy
market
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies
Published:
2024-01-02
(Crawled : 12:00)
- globenewswire.com
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-7.81%
|
O:
-0.86%
H:
1.81%
C:
0.9%
VYGR
|
$7.76
0.26%
210K
|
Health Technology
|
-8.29%
|
O:
24.76%
H:
11.3%
C:
-14.53%
SGMO
|
$0.482
-6.59%
1.4M
|
Health Technology
|
-4.29%
|
O:
-0.17%
H:
9.33%
C:
2.56%
NBIX
M
|
$132.19
-0.78%
250K
|
Health Technology
|
1.12%
|
O:
-1.18%
H:
2.4%
C:
1.18%
license
collaboration
novartis
therapeutics
agreement
Narcolepsy Drugs Market, Size, Global Forecast 2024-2030: Daytime Sleepiness Crucial to the Narcolepsy Drugs Market, Sodium Oxybate Dominates
Published:
2023-12-29
(Crawled : 18:00)
- prnewswire.com
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
narcolepsy
global
Global Progressive Ataxia and Weakness Disorders Treatment Market Report: Focus on Key Players Novartis, Pfizer, Sanofi, GlaxoSmithKline, Roche, Merck, Takeda Pharmaceuticals and Abbott Laboratories
Published:
2023-12-19
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-3.41%
|
O:
-0.39%
H:
1.49%
C:
0.32%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.97%
|
O:
0.8%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-5.3%
|
O:
-0.15%
H:
0.27%
C:
-1.02%
JNJ
|
News
|
$144.54
-0.16%
4.9M
|
Health Technology
|
-6.78%
|
O:
0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$104.91
-0.94%
2.8M
|
Health Technology
|
-0.12%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-5.26%
|
O:
0.21%
H:
0.0%
C:
0.0%
disorders
treatment
pharmaceuticals
global
market
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published:
2023-12-15
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
$140.15
560
|
Health Technology
|
2.12%
|
O:
-3.0%
H:
2.15%
C:
2.15%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.45%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.675
-1.49%
2.1M
|
Health Technology
|
27.07%
|
O:
-0.48%
H:
0.0%
C:
-0.44%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-5.86%
|
O:
-1.31%
H:
0.56%
C:
-0.17%
LLY
|
News
|
$745.46
-0.71%
940K
|
Health Technology
|
26.46%
|
O:
-4.44%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-4.53%
|
O:
-0.93%
H:
0.0%
C:
0.0%
AZN
|
$68.38
-0.22%
2.3M
|
Health Technology
|
2.89%
|
O:
-2.23%
H:
0.28%
C:
-0.11%
reach
research
market
Global Fog Computing Market Research Report 2023-2028 - Emerging Trend of Connected and Modern Vehicles Driving Adoption
Published:
2023-12-14
(Crawled : 00:00)
- prnewswire.com
SNNUF
|
$11.93
710
|
Health Technology
|
-14.17%
|
O:
-2.95%
H:
0.0%
C:
-1.59%
TRUMF
|
$17.112
1.5K
|
Health Technology
|
-48.32%
|
O:
-2.68%
H:
3.46%
C:
3.25%
GLAXF
|
$20.2
510
|
Health Technology
|
10.75%
|
O:
-1.81%
H:
0.0%
C:
-1.79%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.45%
|
O:
0.0%
H:
0.0%
C:
0.0%
TRUMY
|
$16.69
54K
|
Manufacturing
|
-49.47%
|
O:
-1.27%
H:
0.0%
C:
-0.46%
SYK
|
$330.765
-1.57%
730K
|
Health Technology
|
13.1%
|
O:
-3.68%
H:
2.11%
C:
1.39%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-5.86%
|
O:
-1.31%
H:
0.56%
C:
-0.17%
MDT
|
News
|
$78.87
-0.27%
3.6M
|
Health Technology
|
-5.21%
|
O:
-0.42%
H:
0.25%
C:
-0.57%
JNJ
|
News
|
$144.54
-0.16%
4.9M
|
Health Technology
|
-7.51%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GSK
|
$39.2
-1.01%
1.2M
|
Health Technology
|
7.08%
|
O:
-1.84%
H:
0.3%
C:
-1.16%
BSX
|
$67.505
-0.67%
2.5M
|
Health Technology
|
21.25%
|
O:
-0.69%
H:
0.45%
C:
0.04%
BAX
|
News
|
$39.44
-0.2%
1.1M
|
Health Technology
|
1.93%
|
O:
-0.51%
H:
1.08%
C:
-0.13%
ABT
|
News
|
$104.91
-0.94%
2.8M
|
Health Technology
|
0.09%
|
O:
-0.25%
H:
0.0%
C:
0.0%
vehicles
report
research
global
market
Global Home Infusion Therapy Market Report 2023: A $38.71 Billion Industry by 2028 - Emerging Potential in Chemotherapy and Expansion of Specialty Medications and Biologics
Published:
2023-12-14
(Crawled : 10:00)
- prnewswire.com
TRUMF
|
$17.112
1.5K
|
Health Technology
|
-46.88%
|
O:
4.56%
H:
0.02%
C:
-1.7%
TRUMY
|
$16.69
54K
|
Manufacturing
|
-49.94%
|
O:
0.19%
H:
1.5%
C:
-1.11%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-6.65%
|
O:
-1.67%
H:
1.17%
C:
0.85%
BDX
|
$230.84
-0.59%
300K
|
Health Technology
|
-3.93%
|
O:
0.71%
H:
0.48%
C:
-1.52%
ICUI
|
$96.64
0.79%
39K
|
Health Technology
|
4.09%
|
O:
3.37%
H:
6.0%
C:
5.44%
report
expansion
global
home
potential
therapy
market
Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published:
2023-12-14
(Crawled : 01:00)
- prnewswire.com
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-6.65%
|
O:
-1.67%
H:
1.17%
C:
0.85%
JNJ
|
News
|
$144.54
-0.16%
4.9M
|
Health Technology
|
-5.84%
|
O:
1.81%
H:
0.0%
C:
0.0%
BMY
|
$47.895
0.12%
4.6M
|
Health Technology
|
-6.94%
|
O:
1.16%
H:
0.14%
C:
-1.89%
AMGN
|
$263.24
-0.31%
760K
|
Health Technology
|
-5.21%
|
O:
-0.11%
H:
0.5%
C:
-1.78%
cancer
global
immunotherapy
market
Global Melanoma Treatment Market Report 2023, Featuring Comprehensive Profiles of Leading Players including Amgen, Roche, Merck & Co., Pfizer Inc., BMS and Novartis
Published:
2023-12-13
(Crawled : 18:00)
- prnewswire.com
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-6.65%
|
O:
-1.67%
H:
1.17%
C:
0.85%
ARMK
|
$31.405
0.79%
650K
|
Consumer Services
|
14.92%
|
O:
0.88%
H:
1.88%
C:
0.69%
melanoma
report
merck
treatment
global
novartis
market
Alzheimer's Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028; North America to account for 39% of market growth - Technavio
Published:
2023-12-12
(Crawled : 20:00)
- prnewswire.com
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
28.85%
|
O:
-10.21%
H:
0.0%
C:
0.0%
GIKLY
|
$4.6
4.5K
|
Manufacturing
|
-36.02%
|
O:
2.92%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-5.18%
|
O:
0.71%
H:
0.88%
C:
0.85%
ABBV
|
$165.54
0.78%
2.2M
|
Health Technology
|
6.97%
|
O:
-0.17%
H:
1.17%
C:
0.86%
DNLI
|
$16.69
-0.77%
430K
|
Health Technology
|
-10.11%
|
O:
2.9%
H:
8.82%
C:
8.56%
BIIB
|
$190.805
-0.71%
870K
|
Health Technology
|
-21.64%
|
O:
0.09%
H:
2.58%
C:
2.52%
america
disease
alzheimer's
therapeutics
growth
market
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published:
2023-12-12
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.594
2.2K
|
Health Technology
|
-19.72%
|
O:
-0.42%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.46%
|
O:
1.56%
H:
0.51%
C:
0.51%
ALPMY
|
News
|
$9.46
500K
|
Manufacturing
|
-21.38%
|
O:
-5.13%
H:
5.41%
C:
3.46%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-4.32%
|
O:
0.45%
H:
0.75%
C:
0.46%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
2.15%
|
O:
0.18%
H:
0.43%
C:
0.25%
GBIO
|
$2.81
-5.71%
94K
|
Health Technology
|
67.42%
|
O:
5.62%
H:
3.72%
C:
-4.26%
BIIB
|
$190.805
-0.71%
870K
|
Health Technology
|
-20.71%
|
O:
0.59%
H:
1.35%
C:
0.6%
AMGN
|
$263.24
-0.31%
760K
|
Health Technology
|
-1.91%
|
O:
1.83%
H:
0.04%
C:
-1.13%
ADAP
|
$0.8753
-11.32%
2.6M
|
Health Technology
|
104.98%
|
O:
-0.46%
H:
5.56%
C:
-1.12%
ABEO
|
$7.7
-2.9%
170K
|
Health Technology
|
68.33%
|
O:
0.65%
H:
2.59%
C:
0.86%
america
therapy
growth
market
Radiopharmaceuticals market size to grow by USD 4.37 billion from 2021 to 2026 | Actinium Pharmaceuticals Inc., Bayer AG, Bracco Spa, BWX Technologies Inc. and more among the key companies in the market - Technavio
Published:
2023-12-12
(Crawled : 06:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.46%
|
O:
1.56%
H:
0.51%
C:
0.51%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-4.32%
|
O:
0.45%
H:
0.75%
C:
0.46%
FUSN
|
$21.24
260K
|
Health Technology
|
327.36%
|
O:
2.01%
H:
4.73%
C:
3.55%
companies
pharmaceuticals
market
Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published:
2023-12-12
(Crawled : 05:00)
- prnewswire.com
AZNCF
|
$140.15
560
|
Health Technology
|
8.07%
|
O:
5.03%
H:
0.0%
C:
-3.82%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.46%
|
O:
1.56%
H:
0.51%
C:
0.51%
TMO
|
News
|
$542.71
-0.83%
1.2M
|
Health Technology
|
11.38%
|
O:
0.86%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.53
-0.59%
670K
|
Health Technology
|
-4.32%
|
O:
0.45%
H:
0.75%
C:
0.46%
ABBV
|
$165.54
0.78%
2.2M
|
Health Technology
|
8.67%
|
O:
0.59%
H:
1.23%
C:
1.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-2.32%
|
O:
0.43%
H:
0.0%
C:
0.0%
AZN
|
$68.38
-0.22%
2.3M
|
Health Technology
|
7.5%
|
O:
1.54%
H:
0.06%
C:
-0.78%
AMGN
|
$263.24
-0.31%
760K
|
Health Technology
|
-1.91%
|
O:
1.83%
H:
0.04%
C:
-1.13%
growing
growth
market
← Previous
1
2
3
4
5
6
7
8
9
10
…
62
63
Next →
Gainers vs Losers
68%
32%
Top 10 Gainers
AGBA
|
$1.05
162.5%
100M
|
Finance
ISPC
|
$0.4621
116.95%
15M
|
Professional, Scientific, and T...
INVO
|
$1.515
99.34%
4.3M
|
Health Technology
BPTH
|
$5.62
73.46%
75M
|
Health Technology
TIRX
|
$0.8231
69.78%
54M
|
XPON
|
$2.63
36.27%
8.4M
|
PRTG
|
$0.299
35.17%
120K
|
Mining, Quarrying, and Oil and ...
VTNR
S
|
$1.26
28.68%
9.1M
|
Industrial Services
SWVL
|
$9.64
27.35%
200K
|
n/a
DFLI
A
|
$0.7726
25.52%
4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.